Folinic acid and autism: what the evidence actually shows.

In the 1930s, a British doctor named Lucy Wills was working in Mumbai, trying to understand why so many pregnant women in the textile mills were developing a severe anaemia. She suspected something was missing from their food — and, remarkably, corrected it in animals with Marmite. Whatever was doing the work had no name yet. For years it was simply the "Wills Factor."

A decade later, chemists chased the nutrient down and named it after the Latin for leaf, folium. Folate. Folic acid. Then, in 1948, a more active, "pre-digested" version was isolated and — for the next fifty years — used mainly to protect people receiving chemotherapy. That version is folinic acid, sold as leucovorin: inexpensive, long-established, and with a well-mapped safety record in children.

Which is why, decades later, researchers were able to ask an unusual question of an old, familiar compound: in a specific group of autistic children, could it support communication?

Folate has to travel out of the blood and into the brain, carried across by a specific transport protein — a kind of doorway. In some children, the immune system produces antibodies against that doorway, which interfere with how folate crosses.

The result is a specific situation researchers call cerebral folate deficiency: folate levels look completely normal in the blood, while less reaches the brain behind that blocked doorway. A standard blood panel isn't designed to reveal it — which is exactly why it can be missed.

This isn't a failing of any doctor. A standard appointment is structured to identify and manage disease, not to investigate folate transport across the blood–brain barrier. That gap — between "results are normal" and "something still isn't right" — is precisely where a functional investigation begins.

This is the point most online writing gets wrong. The three forms of B9 are not interchangeable, and only one was the compound studied.

The practical point for families: an over-the-counter bottle of folic acid is not a stand-in for the compound in the research, and none of this should be started without a clinician who knows your child.

Most families never see one of these explained. The report itself is short — two lines — but what those two lines mean, and what they don't, is where the clinical work sits. Here is an illustrative sample (not a real person's result), followed by how we read it.

Two antibodies, two questions. The FRAT looks for two different ways the immune system can interfere with the same doorway:

What a positive result means: these antibodies are present. In the context of the wider picture — history, presentation, and the rest of a functional workup — that's a pattern worth taking seriously, and the kind of finding the folate-transport research was built around.

What it doesn't mean: it is not, on its own, a diagnosis. The levels move over time, so a single reading is a snapshot rather than a verdict — which is why repeat testing is sometimes suggested. And a positive result does not decide whether any medication is appropriate; that remains a conversation for a prescribing doctor. Reading a result properly means holding all of that together — which is the work we do in the consultation, alongside your child's medical team.